Skip to main content
Clinical Trials/DRKS00032470
DRKS00032470
Recruiting
未知

Frequency Associated Suppression of Tremor in Parkinson’s Disease and Essential Tremor - FAST

niversität zu Köln, Zentrum für Klinische Studien Köln0 sites45 target enrollmentAugust 14, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Parkinson's Disease, Essential Tremor
Sponsor
niversität zu Köln, Zentrum für Klinische Studien Köln
Enrollment
45
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 14, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversität zu Köln, Zentrum für Klinische Studien Köln

Eligibility Criteria

Inclusion Criteria

  • Uni\- or bilateral implantation of DBS leads in the subthalamic nucleus (PD) or the ventral intermedius nucleus of the thalamus and the posterior subthalamic area (ET) at least 3 months prior to study inclusion and confirmed diagnosis of Parkinson's Disease or Essential Tremor.
  • Patients with Parkinson’s Disease must have a relevant tremor burden defined as \= 2 of 4 points of the MDS\-UPDRS item 3\.17 (rest tremor) without medication, patients with Essential Tremor \=2 of 4 points of item 5/6 of the Fahn Tolosa Marin Tremor Rating Scale (postural or intention tremor).
  • Patients must be able to consent to participate at the study and to give written informed consent prior to study inclusion.

Exclusion Criteria

  • Non\-fulfillment of all inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials